miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive disease arising from T-cell precursors. NOTCH1 plays an important role both in T-cell development and leukemia progression, and more than 60% of human T-ALLs harbor mutations in components of the NOTCH1 signaling pathway, leading to d...

Full description

Bibliographic Details
Main Authors: Valentina Saccomani, Angela Grassi, Erich Piovan, Deborah Bongiovanni, Ludovica Di Martino, Sonia Minuzzo, Valeria Tosello, Paola Zanovello
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/7/1726
_version_ 1797562010924220416
author Valentina Saccomani
Angela Grassi
Erich Piovan
Deborah Bongiovanni
Ludovica Di Martino
Sonia Minuzzo
Valeria Tosello
Paola Zanovello
author_facet Valentina Saccomani
Angela Grassi
Erich Piovan
Deborah Bongiovanni
Ludovica Di Martino
Sonia Minuzzo
Valeria Tosello
Paola Zanovello
author_sort Valentina Saccomani
collection DOAJ
description T-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive disease arising from T-cell precursors. NOTCH1 plays an important role both in T-cell development and leukemia progression, and more than 60% of human T-ALLs harbor mutations in components of the NOTCH1 signaling pathway, leading to deregulated cell growth and contributing to cell transformation. Besides multiple NOTCH1 target genes, microRNAs have also been shown to regulate T-ALL initiation and progression. Using an established mouse model of T-ALL induced by NOTCH1 activation, we identified several microRNAs downstream of NOTCH1 activation. In particular, we found that NOTCH1 inhibition can induce miR-22-3p in NOTCH1-dependent tumors and that this regulation is also conserved in human samples. Importantly, miR-22-3p overexpression in T-ALL cells can inhibit colony formation in vitro and leukemia progression in vivo. In addition, miR-22-3p was found to be downregulated in T-ALL specimens, both T-ALL cell lines and primary samples, relative to immature T-cells. Our results suggest that miR-22-3p is a functionally relevant microRNA in T-ALL whose modulation can be exploited for therapeutic purposes to inhibit T-ALL progression.
first_indexed 2024-03-10T18:23:33Z
format Article
id doaj.art-3ca3afc6952e48418d0b83c6d3708853
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T18:23:33Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-3ca3afc6952e48418d0b83c6d37088532023-11-20T07:12:43ZengMDPI AGCells2073-44092020-07-0197172610.3390/cells9071726miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic LeukemiaValentina Saccomani0Angela Grassi1Erich Piovan2Deborah Bongiovanni3Ludovica Di Martino4Sonia Minuzzo5Valeria Tosello6Paola Zanovello7Department of Surgery, Oncology and Gastroenterology, Immunology & Oncology Section, University of Padova, 35128 Padua, ItalyImmunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV—IRCCS, 35128 Padua, ItalyDepartment of Surgery, Oncology and Gastroenterology, Immunology & Oncology Section, University of Padova, 35128 Padua, ItalyDepartment of Surgery, Oncology and Gastroenterology, Immunology & Oncology Section, University of Padova, 35128 Padua, ItalyDepartment of Surgery, Oncology and Gastroenterology, Immunology & Oncology Section, University of Padova, 35128 Padua, ItalyDepartment of Surgery, Oncology and Gastroenterology, Immunology & Oncology Section, University of Padova, 35128 Padua, ItalyImmunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV—IRCCS, 35128 Padua, ItalyDepartment of Surgery, Oncology and Gastroenterology, Immunology & Oncology Section, University of Padova, 35128 Padua, ItalyT-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive disease arising from T-cell precursors. NOTCH1 plays an important role both in T-cell development and leukemia progression, and more than 60% of human T-ALLs harbor mutations in components of the NOTCH1 signaling pathway, leading to deregulated cell growth and contributing to cell transformation. Besides multiple NOTCH1 target genes, microRNAs have also been shown to regulate T-ALL initiation and progression. Using an established mouse model of T-ALL induced by NOTCH1 activation, we identified several microRNAs downstream of NOTCH1 activation. In particular, we found that NOTCH1 inhibition can induce miR-22-3p in NOTCH1-dependent tumors and that this regulation is also conserved in human samples. Importantly, miR-22-3p overexpression in T-ALL cells can inhibit colony formation in vitro and leukemia progression in vivo. In addition, miR-22-3p was found to be downregulated in T-ALL specimens, both T-ALL cell lines and primary samples, relative to immature T-cells. Our results suggest that miR-22-3p is a functionally relevant microRNA in T-ALL whose modulation can be exploited for therapeutic purposes to inhibit T-ALL progression.https://www.mdpi.com/2073-4409/9/7/1726miR-22-3pT-ALLNOTCH1
spellingShingle Valentina Saccomani
Angela Grassi
Erich Piovan
Deborah Bongiovanni
Ludovica Di Martino
Sonia Minuzzo
Valeria Tosello
Paola Zanovello
miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
Cells
miR-22-3p
T-ALL
NOTCH1
title miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
title_full miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
title_fullStr miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
title_full_unstemmed miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
title_short miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
title_sort mir 22 3p negatively affects tumor progression in t cell acute lymphoblastic leukemia
topic miR-22-3p
T-ALL
NOTCH1
url https://www.mdpi.com/2073-4409/9/7/1726
work_keys_str_mv AT valentinasaccomani mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia
AT angelagrassi mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia
AT erichpiovan mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia
AT deborahbongiovanni mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia
AT ludovicadimartino mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia
AT soniaminuzzo mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia
AT valeriatosello mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia
AT paolazanovello mir223pnegativelyaffectstumorprogressionintcellacutelymphoblasticleukemia